Taking iron supplements during menstrual bleeding.
Conditions
Interventions
Intervention 1: Intervention group: Ferrous sulfate iron tablets containing 50 mg of iron ions are prepared by Amin Pharmaceutical Company. The intervention group will be given 12 iron pills to take t
Sponsors
Rafsanjan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Conscious and free written satisfaction to participate in the study Lack of vitamin intake and iron supplementation in the last three months Lack of pregnancy and lactation Not using oral and injectable steroid hormonal drugs Lack of known parasitic and infectious diseases Lack of blood diseases such as thalassemia and hemophilia No known history of psychiatric disorders Lack of endocrine disorders such as diabetes and thyroid problems Lack of Contraindications Iron Consumption: Receiving blood frequently -Intake of intravenous iron-absorption disorder and excessive iron storage such as hemochromatosis Not being a smoker Not taking mineral supplements at the moment Not taking herbal medicines and supplements for two weeks before the start of the study and throughout the study BMI between 18.5 to 25 kg / m2 Hemoglobin greater than or equal to 12 grams per deciliter (not being anemic) Having a normal menstrual cycle between 21-35 days and no known history of menorrhagia Not having a recent history of major surgery and an accident leading to a blood transfusion Lack of digestive problems (risk of iron deficiency disorders) -No use of tampons or menstrual cups
Exclusion criteria
Exclusion criteria: The occurrence of allergic reactions to iron tablets Forget about taking more than one iron pill per cycle Take emergency contraceptive pills in each cycle
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menstrual bleeding rate. Timepoint: Before the intervention and after each intervention (three menstrual cycles). Method of measurement: Higham chart (pictorial blood assessment chart).;Blood hemoglobin level. Timepoint: Before the intervention and one week after taking the last iron pill or placebo. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzeyeh Loripoor
Rafsanjan University of Medical Sciences
Outcome results
None listed